Fundraising Fox

Kunio Matsumoto

代表取締役 Chief Executive Officer at Vision Incubate

About

Ph.D. in science; professor at Kanazawa University's Nano Life Science Institute and vice-president for industry-academia collaboration. Founded Kringle Pharma in 2001 (listed on Tokyo Stock Exchange Mothers in 2020), developing HGF-based therapies for intractable diseases.

Colleagues at Vision Incubate